That’s what this drug company is trying to do. It probably would be better to spend their resources trying to find something new, rather than repackaging old drugs (case in point: BiDil).
Do we really need brand name amoxicillin?
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
More in Uncategorized
Past Week
-
What happened to real care in health care?
-
How doctors can thrive despite declining reimbursements
-
Pope Francis dies at 88. What his care reveals about America’s failing hospitals.
-
Calling for a heart surgeon: a plea for change
-
Why ADHD isn’t just a childhood disorder and what that means for adults
-
Why prescribing medicine to kids scares even experienced doctors
-
Past 6 Months
-
How trade wars could destroy the U.S. health care system
-
How hospitals are quietly taking control of physicians
-
The hidden bias young female physicians face every day
-
How the system hunts physicians who refuse to kneel
-
Doctors don’t need yoga, they need time to smoke
-
How to advocate for your transgender child’s health care
-
Recent Posts
-
Why ADHD isn’t just a childhood disorder and what that means for adults
-
Customer relationship management tools to beat physician burnout and regain practice control [PODCAST]
-
Rural hospitals are vanishing—and lives are vanishing with them
-
Medical gaslighting has emerged as a troubling issue for both patients and health care providers
-
Third-party litigation funding threatens access to health care
-
Fat guy in a little coat: Preventing childhood obesity
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
